Xeris Biopharma Holdings, Inc. $XERS Shares Acquired by AQR Capital Management LLC - MarketBeat
1 hour ago • Google News
Xeris Pharmaceuticals Inc (XERS)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.24B
P/E Ratio
0.00
Revenue (TTM)
$ 246.02M
Volume
0
52W High
$ 8.03
52W Low
$ 2.69
Dividend Yield
0.00%
Beta
0.91
Technicals
50-Day MA
6.5904
200-Day MA
4.794
52 Week High
8.03
52 Week Low
2.69
About XERS
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
Employees
394
Headquarters
Chicago, IL
CEO
Mr. John P. Shannon